Short-Term Biotech Impact Mild, Long-Term Remains to be Seen

The biotech industry tends to be somewhat resistant to macroeconomic forces, given the constant demand for healthcare. But the industry isn't totally insulated from the recent events on Wall Street, including Lehman's bankruptcy, Merrill Lynch's acquisition by Bank of America and the news that Goldman Sachs and Morgan Stanley are moving into commercial banking. (BioWorld Financial Watch)